Nanoparticles Against Antimicrobial Resistance: Chemical Design, Assembly, and Emerging Applications.
4 affiliations
- 1Department of Chemistry, University of Oslo, Postboks 1033 Blindern, 0315Oslo, Norway.
- 2Department of Science and Environment, Roskilde University, Universitetsvej 14000Roskilde, Denmark.
- 3Hylleraas Centre for Quantum Molecular Sciences, University of Oslo, Postboks 1033 Blindern, 0315Oslo, Norway.
- 4Donostia International Physics Centre (DIPC), Manuel Lardizabal Ibilbidea, 4, 20018Donostia/San Sebastián, Gipuzkoa, Spain.
Abstract
Antimicrobial resistance (AMR) is an escalating global health concern, with increasing rates of morbidity and mortality associated with multidrug-resistant infections worldwide. Despite intensive efforts to discover antimicrobial compounds, few candidates progress to clinical trials, and even fewer achieve market approval. A promising approach to address the current stagnation in antibiotic discovery is the development of advanced antimicrobial delivery platforms, which can enhance the efficacy, stability, and reusability of both existing and engineered antimicrobial agents. In this review, we provide an overview of the literature on the preclinical and clinical development of antimicrobial agents, as well as the integration of both existing and emerging agents into advanced delivery systems. These include inorganic nanoparticles (e.g., metal- and silicon-based) as well as (supramolecular) organic nanoparticles such as polymeric micelles, dendrimers, vesicles, polyelectrolyte complexes, hydrogels, lipid micelles, liposomes, lipid nanoparticles, emulsions, and hybrid formulations, among others. Using a soft matter science perspective, we discuss these nanoparticle scaffolds as platforms for incorporating antimicrobial compounds via encapsulation, conjugation, adsorption, entrapment, self-assembly, co-assembly, or driven-assembly strategies. While many of these delivery systems show substantial promise, key challenges, including technical limitations, toxicity, and immunogenicity, must be addressed before clinical translation. By reviewing recent advances and innovations, we highlight how nanotechnology-enabled delivery systems can overcome challenges posed by AMR and potentially shape the future of antimicrobial therapies.
Related
- Multifunctional Antibacterial Nanocomposites Based on Graphene Oxide, Graphitic Carbon Nitride, and Cobalt Ferrite Functionalized with an Antimicrobial Polymer Blend and Silver Nanoparticles for Biomedical and Environmental Applications
- Cucurbit[7]uril-mediated aqueous self-assembly and supramolecular functionalisation of selenium nanoparticles
- Green Synthesis of Silver Nanoparticles Using Ammoides pusilla Extract: Optimization, Characterization, and Antimicrobial Activity
- Gold Shell-Isolated Nanoparticles Differentially Affect Neutrophil Antimicrobial Function
- Biocomposite Microparticles Incorporating Ibuprofen and ZnO Nanoparticles for Controlled Drug Delivery and Antimicrobial Therapy
BibTeX
@article{vogelaar2026nanoparticles,
title = {{Nanoparticles Against Antimicrobial Resistance: Chemical Design, Assembly, and Emerging Applications.}},
author = {Thomas Daniel Vogelaar and Håvard Jenssen and Reidar Lund},
journal = {ACS nano},
year = {2026},
month = sep,
doi = {10.1021/acsnano.6c09306},
url = {https://europepmc.org/article/MED/42915754},
note = {CC BY},
}
RIS
TY - JOUR
TI - Nanoparticles Against Antimicrobial Resistance: Chemical Design, Assembly, and Emerging Applications.
AU - Thomas Daniel Vogelaar
AU - Håvard Jenssen
AU - Reidar Lund
PY - 2026
DA - 2026/09/01
JO - ACS nano
DO - 10.1021/acsnano.6c09306
UR - https://europepmc.org/article/MED/42915754
AB - Antimicrobial resistance (AMR) is an escalating global health concern, with increasing rates of morbidity and mortality associated with multidrug-resistant infections worldwide. Despite intensive efforts to discover antimicrobial compounds, few candidates progress to clinical trials, and even fewer achieve market approval. A promising approach to address the current stagnation in antibiotic discovery is the development of advanced antimicrobial delivery platforms, which can enhance the efficacy, stability, and reusability of both existing and engineered antimicrobial agents. In this review, we provide an overview of the literature on the preclinical and clinical development of antimicrobial agents, as well as the integration of both existing and emerging agents into advanced delivery systems. These include inorganic nanoparticles (e.g., metal- and silicon-based) as well as (supramolecular) organic nanoparticles such as polymeric micelles, dendrimers, vesicles, polyelectrolyte complexes, hydrogels, lipid micelles, liposomes, lipid nanoparticles, emulsions, and hybrid formulations, among others. Using a soft matter science perspective, we discuss these nanoparticle scaffolds as platforms for incorporating antimicrobial compounds via encapsulation, conjugation, adsorption, entrapment, self-assembly, co-assembly, or driven-assembly strategies. While many of these delivery systems show substantial promise, key challenges, including technical limitations, toxicity, and immunogenicity, must be addressed before clinical translation. By reviewing recent advances and innovations, we highlight how nanotechnology-enabled delivery systems can overcome challenges posed by AMR and potentially shape the future of antimicrobial therapies.
SN - 1936-0851
SN - 1936-086X
ER -